Recombinant Nitrosomonas europaea GMP synthase [glutamine-hydrolyzing] (guaA), partial, refers to a genetically engineered version of the enzyme GMP synthase from the bacterium Nitrosomonas europaea. This enzyme is crucial in purine metabolism, specifically in the conversion of xanthosine monophosphate (XMP) to guanosine monophosphate (GMP), utilizing glutamine as an amino group donor and ATP for energy .
GMP synthase is an amidotransferase that catalyzes the amination of XMP to form GMP. The reaction involves two main steps: glutamine hydrolysis to produce ammonia, and the subsequent amination of XMP using this ammonia. The enzyme consists of two functional domains: a glutaminase domain responsible for glutamine hydrolysis and a synthetase domain that catalyzes the formation of GMP from XMP .
The enzyme structure typically includes a class I amidotransferase domain for glutamine hydrolysis and an ATP pyrophosphatase domain for GMP synthesis. The amidotransferase domain contains a conserved catalytic triad, often involving cysteine, histidine, and glutamic acid residues, which facilitate the removal of the amide nitrogen from glutamine .
Recombinant expression of GMP synthase allows for the production of large quantities of the enzyme, which can be used in various biochemical and biotechnological applications. This includes studying enzyme kinetics, understanding nitrogen metabolism in bacteria, and potentially developing new biocatalysts for nucleotide synthesis .
While specific data on the recombinant Nitrosomonas europaea GMP synthase (guaA), partial, might be limited, general research on GMP synthases highlights their importance in purine metabolism and their potential as targets for drug development or metabolic engineering.
| Feature | Description |
|---|---|
| Enzyme Class | Amidotransferase (EC 6.3.5.2) |
| Reaction | Converts XMP to GMP using glutamine and ATP |
| Domains | Glutaminase and synthetase domains |
| Catalytic Triad | Typically involves Cys, His, and Glu residues |
| Applications | Biochemical studies, biotechnology, drug development |
Catalyzes the synthesis of GMP from XMP.
KEGG: neu:NE0094
STRING: 228410.NE0094
Nitrosomonas europaea is a gram-negative obligate chemolithoautotroph that derives all energy and reductant for growth from the oxidation of ammonia to nitrite, playing a crucial role in the biogeochemical nitrogen cycle through nitrification . Its significance stems from its unique metabolism, complete genome sequence (consisting of a single circular chromosome of 2,812,094 bp with 2,460 protein-encoding genes), and its potential applications in environmental monitoring and bioremediation . N. europaea has well-characterized gene clusters that enable ammonia oxidation and various stress responses, making it an excellent model organism for studying chemolithoautotrophic metabolism .
GMP synthase [glutamine-hydrolyzing] (guaA) catalyzes the ATP-dependent conversion of xanthosine 5'-monophosphate (XMP) to guanosine 5'-monophosphate (GMP) using glutamine as an amide donor. While the specific characterization of guaA in N. europaea is not directly addressed in the available research, this enzyme is essential for de novo purine biosynthesis in bacteria. In the context of N. europaea's genome, which contains genes necessary for biosynthesis, CO₂ and NH₃ assimilation , guaA would play a critical role in nucleotide metabolism supporting the organism's growth and stress responses.
The N. europaea genome consists of 2,460 protein-encoding genes averaging 1,011 bp in length, with intergenic regions averaging 117 bp . While specific information about the genomic context of guaA is not provided in the search results, the genome analysis reveals that genes are distributed evenly around the genome, with approximately 47% transcribed from one strand and 53% from the complementary strand . Unlike many heterotrophic bacteria, N. europaea has limited genes for catabolism of organic compounds but contains numerous genes for inorganic ion transporters, reflecting its chemolithoautotrophic lifestyle .
Successful transformation of N. europaea has been achieved using plasmid vectors containing promoter regions from genes of interest. For example, transcriptional fusions with green fluorescent protein (GFP) driven by the promoter regions of mbla (NE2571) in pPRO/mbla4 and clpB (NE2402) in pPRO/clpb7 have been successfully used to transform N. europaea (ATCC 19718) . Additionally, suicide vectors harboring internal fragments of target genes (e.g., norB or norQ) transferred from Escherichia coli to wild-type cells of N. europaea via conjugation have been employed for gene disruption through homologous recombination . These methodologies provide a foundation for creating recombinant N. europaea strains expressing modified guaA.
Based on successful approaches with other N. europaea genes, researchers could create transcriptional fusions where the guaA promoter drives expression of a reporter gene such as GFP . This system would allow monitoring of guaA expression under various environmental conditions, including different ammonia concentrations, exposure to oxidative stress (e.g., H₂O₂), or presence of xenobiotics like chlorinated compounds. For example, previous work demonstrated that GFP-dependent fluorescence in N. europaea transformed with pPRO/mbla4 increased 3- to 18-fold above control levels in response to increasing chloroform concentrations (7 to 28 μM) and 8- to 10-fold in response to increasing hydrogen peroxide concentrations (2.5-7.5 mM) . A similar approach could reveal conditions that influence guaA expression.
To investigate guaA's role in stress responses, researchers should consider:
Gene disruption: Creating guaA-deficient strains through insertion of suicide vectors via homologous recombination, similar to methods used for norB and norQ genes .
Complementation studies: Introducing an intact guaA gene in trans to confirm phenotypic changes are due to guaA disruption .
Stress exposure assays: Comparing wild-type and guaA-deficient strains' responses to stressors such as reactive nitrogen species, oxidative stress, or chlorinated compounds .
Growth kinetics analysis: Measuring growth parameters (rate, yield) under various stress conditions, as performed with NorB-deficient cells exposed to sodium nitroprusside (SNP) .
Metabolite profiling: Analyzing changes in purine nucleotide pools and related metabolites in response to stress.
Based on successful approaches with other N. europaea proteins, consider the following optimization strategy:
Expression System Selection:
Evaluate both homologous expression in N. europaea and heterologous expression in E. coli
For homologous expression, use promoters known to function in N. europaea, such as those of mbla or clpB genes
For heterologous expression, consider using E. coli strains designed for expression of proteins with complex folding requirements
Purification Strategy:
Employ affinity tags (His, GST) for initial purification
Include stabilizing agents in buffers (glycerol, reducing agents)
Consider fusion partners that enhance solubility if initial expression yields insoluble protein
Implement multi-step purification using ion exchange and size exclusion chromatography
Monitor enzyme activity throughout purification to ensure preservation of function
Activity Preservation:
Determine optimal pH and temperature conditions based on N. europaea's natural environment
Include necessary cofactors (ATP, Mg²⁺) and substrates (glutamine) in stabilization buffers
Test the effect of various storage conditions (temperature, buffer composition) on long-term stability
For creating precise mutations in N. europaea guaA, consider:
In vitro mutagenesis approaches:
PCR-based site-directed mutagenesis on cloned guaA gene
Gibson Assembly for larger modifications or domain swaps
Golden Gate Assembly for multiple mutations in parallel
In vivo genome editing:
Target selection guidance:
Focus on catalytic residues predicted from alignment with characterized GMP synthases
Investigate residues potentially involved in ammonia-specific regulation
Examine domain interfaces to understand subunit interactions
Validation methods:
Sequencing to confirm mutations
Enzymatic assays to measure changes in catalytic parameters
Structural analysis (if possible) to confirm predicted effects
| Method | Principle | Sensitivity | Advantages | Limitations |
|---|---|---|---|---|
| HPLC Analysis | Direct measurement of GMP production | Moderate | Directly quantifies product, high specificity | Requires specialized equipment, time-consuming |
| Spectrophotometric Assay | Coupled reaction measuring NADH oxidation | Moderate | Real-time monitoring, relatively simple | Potential interference from other cellular components |
| Radiometric Assay | Tracking conversion of labeled substrates | High | Excellent sensitivity, works with crude extracts | Requires radioactive materials, special handling |
| Mass Spectrometry | Direct measurement of substrates/products | Very High | Highly specific, can measure multiple metabolites | Expensive equipment, complex sample preparation |
When comparing wild-type and recombinant strains, ensure consistent:
Cell growth conditions (similar to those used for studying NorB-deficient strains )
Cell disruption methods
Protein quantification for normalization
Assay conditions (pH, temperature, substrate concentrations)
Inclusion of appropriate controls (heat-inactivated extracts, reactions without key substrates)
When analyzing guaA expression changes in N. europaea, consider the following interpretative framework:
Contextual evaluation: N. europaea's metabolism is centered around ammonia oxidation, with genes necessary for catabolism of ammonia, energy generation, biosynthesis, and CO₂/NH₃ assimilation . Changes in guaA expression should be interpreted within this unique metabolic context.
Integration with nitrogen metabolism: Consider whether changes correlate with nitrogen oxidation rates or nitrite accumulation, similar to how norCBQD expression relates to nitrogen oxide metabolism .
Stress response correlation: Evaluate whether guaA expression changes coincide with other stress responses, as observed with mbla and clpB genes which respond to chloroform and H₂O₂ exposure .
Temporal dynamics: Analyze expression patterns across growth phases, considering N. europaea's relatively slow growth rate as a chemolithoautotroph.
Regulatory networks: Explore potential regulatory factors, such as the Fnr transcription factor studied in relation to norCBQD expression , which might influence guaA transcription under different conditions.
For robust statistical analysis of guaA data:
Experimental design considerations:
Use a minimum of 3-5 biological replicates per condition
Include technical replicates to account for measurement variability
Implement appropriate controls for each condition tested
For expression data analysis:
For continuous measurements (e.g., fluorescence from GFP reporter fusions ): ANOVA with post-hoc tests for multiple comparisons
For time-course experiments: repeated measures ANOVA or mixed-effects models
For binary comparisons: t-tests or non-parametric alternatives if normality assumptions are violated
Dose-response relationships:
Data transformation:
Log transformation for skewed data
Normalization to internal controls for reducing batch effects
Visualization approaches:
Box plots for showing distribution of responses across conditions
Heat maps for multi-parameter experiments
Principal component analysis for complex datasets with multiple variables
To establish causality between guaA modifications and observed phenotypes:
Complementation analysis: Reintroduce wild-type guaA into mutant strains to determine if the original phenotype is restored, similar to the complementation approach used with norCBQD genes .
Dose-dependency tests: Create strains with varying levels of guaA expression to establish correlation between expression level and phenotype intensity.
Site-directed mutagenesis: Generate specific mutations affecting different aspects of guaA function (e.g., catalytic activity versus protein stability) to pinpoint the molecular basis of phenotypic changes.
Off-target effect exclusion: Use genome sequencing or targeted PCR to confirm absence of unintended mutations in other genes.
Metabolite supplementation: Test if providing GMP or related metabolites can rescue phenotypic defects, confirming the metabolic basis of the observed changes.
Comparative analysis with related genes: Examine whether similar phenotypes occur when related purine biosynthesis genes are modified, to determine pathway-specific versus gene-specific effects.
Creating stable guaA knockouts may be challenging if the gene is essential. Consider these strategies:
Conditional knockout systems:
Inducible promoter control of guaA expression
Temperature-sensitive alleles
Antisense RNA approaches to reduce but not eliminate expression
Media supplementation:
Provide guanine or guanosine in growth media to potentially complement GMP synthase deficiency
Optimize ammonia concentrations to reduce metabolic stress on mutants
Alternative disruption strategies:
Partial gene deletions that maintain some function
Point mutations in catalytic residues rather than complete gene removal
Insertion of regulatory elements to modulate rather than eliminate expression
Technical optimization:
Validation approaches:
Based on successful GFP reporter studies in N. europaea , address inconsistent signals by:
Construct design optimization:
Ensure appropriate promoter fragment length (including all regulatory elements)
Optimize ribosome binding site for efficient translation
Consider codon optimization of GFP for N. europaea
Experimental conditions:
Standardize growth conditions (media composition, temperature, oxygen availability)
Control for ammonia/nitrite concentrations which may affect cellular metabolism
Establish consistent time points for measurements relative to growth phase
Signal detection:
Optimize excitation/emission parameters for N. europaea autofluorescence minimization
Implement appropriate blank controls to account for media fluorescence
Consider flow cytometry for single-cell analysis to identify population heterogeneity
Validation approaches:
Technical considerations:
Ensure consistent protein extraction methods if measuring cell lysates
Normalize fluorescence to cell density or total protein
Account for cellular stress responses that might indirectly affect GFP expression
To enhance purification of active guaA protein:
Expression optimization:
Test multiple expression systems (N. europaea, E. coli, cell-free)
Vary induction conditions (temperature, inducer concentration, duration)
Evaluate different fusion tags (His, GST, MBP) for improved solubility
Buffer optimization:
Include stabilizing agents (glycerol, reducing agents, specific ions)
Test pH ranges based on N. europaea's physiological pH preference
Add enzyme cofactors (ATP, Mg²⁺) and substrate analogs for stability
Purification strategy refinement:
Implement gentle extraction methods to preserve native conformation
Consider rapid purification protocols to minimize time for denaturation
Evaluate on-column refolding if inclusion bodies form
Use size exclusion chromatography to isolate properly folded multimers
Activity preservation:
Determine optimal storage conditions (temperature, buffer composition)
Test cryoprotectants for freeze-thaw stability
Consider lyophilization with appropriate excipients
Evaluate enzyme kinetics throughout purification to identify steps causing activity loss
Structural considerations:
Analyze protein sequence for potential problematic regions (hydrophobic patches, disordered segments)
Consider expressing individual domains separately if full-length protein proves difficult
Implement site-directed mutagenesis to enhance stability without affecting catalytic function
N. europaea has demonstrated stress responses to chlorinated compounds like chloroform, with genes such as mbla and clpB showing increased expression . Future research could investigate:
Whether guaA expression or GMP synthase activity changes in response to environmental pollutants, similar to the 3-18 fold increase in GFP fluorescence observed with the mbla promoter in response to chloroform
If guaA plays a role in nucleotide metabolism adjustments during xenobiotic stress, potentially supporting DNA repair mechanisms
Whether purine nucleotide availability affects the expression or function of stress response proteins in N. europaea
If guaA could serve as an additional "sentinel" gene for biosensor development, complementing the existing mbla and clpB-based biosensors that respond to chloroform and hydrogen peroxide
The potential role of guaA in cross-talk between nitrogen metabolism and stress response pathways, considering N. europaea's unique chemolithoautotrophic lifestyle
Comparative analysis could explore:
Sequence conservation and divergence of guaA among ammonia-oxidizing bacteria compared to heterotrophic bacteria
Correlation between guaA sequence variations and ecological parameters (pH, temperature, ammonia concentration) in different niches
Regulatory differences in guaA expression that might reflect adaptation to specific environmental conditions
Whether horizontal gene transfer has influenced guaA evolution in ammonia-oxidizing bacteria
Potential co-evolution of guaA with ammonia oxidation machinery, considering N. europaea's specialized metabolism that derives all energy from ammonia oxidation
Building on the successful development of biosensors using mbla and clpB promoters in N. europaea , recombinant guaA could contribute to biosensor technology by:
Providing an additional promoter-reporter system if guaA expression responds to specific environmental conditions or pollutants
Serving as a metabolic indicator for nitrogen cycling processes if guaA expression correlates with ammonia oxidation rates
Contributing to multi-parameter biosensors that simultaneously monitor different aspects of environmental health
Potentially improving existing biosensor sensitivity or specificity through protein engineering of guaA-based sensing elements
Enabling detection of compounds that specifically affect purine metabolism but might not trigger general stress responses